Liminatus Pharma, Inc. - LIMN
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Jul 22, 2026 | SCHEDULE 13G | Samda Biolab Co., Ltd. | 5.1% | 3,426,548 | View |
| Jul 14, 2026 | SCHEDULE 13D/A | — | — | — | View |
| Jul 06, 2026 | SCHEDULE 13G/A | Ewon Comfortech Co., Ltd. | 10.9% | 5,500,000 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.